Cyclin E2 Antibody - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-99464
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Format
Concentration
Product Specifications
Immunogen
Clonality
Host
Isotype
Description
Scientific Data Images for Cyclin E2 Antibody - Azide and BSA Free
Immunocytochemistry/Immunofluorescence: Cyclin E2 Antibody [NBP2-99464] -
Immunocytochemistry/Immunofluorescence: Cyclin E2 Antibody [NBP2-99464] - Immunofluorescence staining of Cyclin E2 in HeLa cells. Cells were fixed with 4% PFA, permeabilzed with 0.1% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-99464 antibody (dilution ratio 1:1000) at 4C overnight. Then cells were stained with the Alexa Fluor(R)488-conjugated Goat Anti-rabbit IgG Secondary antibody (green). Positive staining was localized to nucleus and cytoplasm.Applications for Cyclin E2 Antibody - Azide and BSA Free
Immunocytochemistry/ Immunofluorescence
Formulation, Preparation, and Storage
Purification
Formulation
Format
Preservative
Concentration
Shipping
Stability & Storage
Background: Cyclin E2
Cyclin E2 (CCNE2) is an approximately 45-50 kDa protein that associates with the kinase Cdk2. This complex phosphorylates multiple substrates involved in regulation of cell cycle progression and the initiation of DNA replication. Cyclin E2 is required for G1/S phase progression and cell cycle reentry from G0 phase. Cyclin E2 most highly expressed in testis, thymus, and brain and is frequently upregulated in cancer. Cyclin E2 contains two cyclin box folds (aa 141-231 and aa 241-361). An alternate splice form lacks 45 amino acids within the first cyclin box fold.
Alternate Names
Gene Symbol
Additional Cyclin E2 Products
Product Documents for Cyclin E2 Antibody - Azide and BSA Free
Product Specific Notices for Cyclin E2 Antibody - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.